HDAC5 and pulmonary arterial hypertension: In contrast, increased expression of HDAC3, HDAC4, and HDAC5 is associated with induction of Nox2 and Nox4 in pulmonary arterial hypertension, which was decreased by the HDAC inhibitor, valproic acid [58].